Trial Profile
Phase I bioequivalence trial of extended- versus immediate-release formulation of topiramate, and the effects of food on extended-release topiramate pharmacokinetics in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 May 2016
Price :
$35
*
At a glance
- Drugs Topiramate (Primary)
- Indications Epilepsy; Migraine
- Focus Pharmacokinetics
- 21 Apr 2016 Results of pooled analysis from three phase I and two phase III studies assessing the differentiating features of Topiramate (extented release capsules and immediate release) presented at the 68th Annual Meeting of the American Academy of Neurology
- 06 Dec 2011 Results were presented at the 65th Annual Meeting of the American Epilepsy Society (AES-2011)
- 26 Sep 2011 Results were presented at the Annual Meeting of the American Neurological Associations (ANA-2011).